DHC logo

Diversified Healthcare Trust Stock Price

NasdaqGS:DHC Community·US$2.1b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author

DHC Share Price Performance

US$8.82
8.82 (0.00%)
US$9.88
Fair Value
US$8.82
8.82 (0.00%)
10.7% undervalued intrinsic discount
US$9.88
Fair Value
Price US$8.82
AnalystConsensusTarget US$9.88
AnalystHighTarget US$11.00
AnalystLowTarget US$8.00

DHC Community Narratives

·
Fair Value US$9.88 10.7% undervalued intrinsic discount

Aging US Population And Outpatient Care Demand Will Transform Markets

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
·
Fair Value US$11 19.8% undervalued intrinsic discount

Aging Populations And Telehealth Trends Will Uplift Facilities

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value US$8 10.3% overvalued intrinsic discount

Elevated Debt And Regulatory Pressure Will Weaken Senior Housing

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

Trending Discussion

No trending discussion available.

Updated Narratives

DHC logo

DHC: 2026 Expense Savings And SHOP Repositioning Will Support Re Rating

Fair Value: US$11 19.8% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
DHC logo

DHC: 2026 Guidance And SHOP Repositioning Will Support Balanced Risk Profile

Fair Value: US$9.88 10.7% undervalued intrinsic discount
2 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
DHC logo

DHC: Expense Savings Driven 2026 Outlook Will Face Execution Risk

Fair Value: US$8 10.3% overvalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Undervalued with adequate balance sheet.

1 Risk
2 Rewards

Diversified Healthcare Trust Key Details

US$1.5b

Revenue

US$1.2b

Cost of Revenue

US$279.2m

Gross Profit

US$545.1m

Other Expenses

-US$266.0m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
-1.10
18.61%
-17.73%
151.8%
View Full Analysis

About DHC

Founded
1998
Employees
n/a
CEO
Christopher Bilotto
WebsiteView website
www.dhcreit.com

Diversified Healthcare Trust is a real estate investment trust, or REIT, focused on owning high-quality healthcare properties located throughout the United States. DHC’s portfolio is anchored by a strategically curated mix of senior housing, medical office and life science assets that combine high quality care, modern technology and amenity rich environments to meet rising demand across the healthcare continuum. As of June 30, 2026, DHC’s approximately 6.3 billion dollar portfolio included 285 properties in 33 states and Washington, D.C., with 23,797 senior living units, approximately 5.6 million square feet of medical office and life science properties and occupied by approximately 250 tenants. DHC is managed by The RMR Group, a leading U.S. alternative asset management company with over 37 billion dollar in assets under management as of June 30, 2026 and 40 years of institutional experience in buying, selling, financing and operating commercial real estate. DHC is headquartered in Newton, Massachusetts. Diversified Healthcare Trust was established in 1998 and is incorporated in Maryland.

Recent DHC News & Updates

Narrative Update Jul 21

DHC: 2026 Expense Savings And SHOP Repositioning Will Support Re Rating

The analyst price target for Diversified Healthcare Trust has increased from $10.00 to $11.00, with analysts highlighting the company’s progress in repositioning its SHOP portfolio, pursuing revenue-focused projects, and updating guidance on expense savings and 2026 earnings potential. Analyst Commentary Recent research on Diversified Healthcare Trust points to a cluster of constructive views, with several bullish analysts lifting price targets and highlighting the company’s execution on portfolio repositioning, revenue projects, and updated guidance through 2026.

Recent updates

No updates